TY - JOUR
T1 - Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients
AU - Walsh, T. J.
AU - Hiemenz, J. W.
AU - Anaissie, E.
PY - 1996/1/1
Y1 - 1996/1/1
N2 - Patients who are receiving cytotoxic chemotherapy for neoplastic diseases, including those receiving allogeneic bone marrow transplantation, are predisposed to develop invasive fungal infections as the result of host defense impairments due to intensive cytotoxic chemotherapy, ablative radiation therapy, corticosteroids, cyclosporine, and the underlying neoplastic process. This article reviews the current approaches and problems in diagnosis, treatment, and prevention of invasive fungal infections in neutropenic patients.
AB - Patients who are receiving cytotoxic chemotherapy for neoplastic diseases, including those receiving allogeneic bone marrow transplantation, are predisposed to develop invasive fungal infections as the result of host defense impairments due to intensive cytotoxic chemotherapy, ablative radiation therapy, corticosteroids, cyclosporine, and the underlying neoplastic process. This article reviews the current approaches and problems in diagnosis, treatment, and prevention of invasive fungal infections in neutropenic patients.
UR - http://www.scopus.com/inward/record.url?scp=0029933706&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029933706&partnerID=8YFLogxK
U2 - 10.1016/S0891-5520(05)70303-2
DO - 10.1016/S0891-5520(05)70303-2
M3 - Article
C2 - 8803625
AN - SCOPUS:0029933706
SN - 0891-5520
VL - 10
SP - 365
EP - 400
JO - Infectious disease clinics of North America
JF - Infectious disease clinics of North America
IS - 2
ER -